This page shows the latest Scottish Medicines Consortium news and features for those working in and with pharma, biotech and healthcare.
Mayzent (siponimod), a sphinogosine 1-phosphate receptor modulator, is the first oral disease-modifying treatment recommended by both NICE and the Scottish Medicines Consortium (SMC) for SPMS with active disease.
The UK’s medicines watchdog NICE and the Scottish Medicines Consortium recently backed the use of Mulpleo in this patient population after determining that the drug was cost-effective.
Drug is being reviewed under new ultra-orphan pathway. The Scottish Medical Consortium has enabled access to Japanese pharma Kyowa Kirin's Crysvita, a novel treatment for a rare inherited bone ... England’s cost-effectiveness watchdog NICE issued a
It has since been backed by the Scottish Medicines Consortium (SMC) for reimbursement on the NHS.
Pressure to reach a deal in England mounts. Following an initial rejection from the Scottish Medicines Consortium (SMC), Vertex has reached an agreement for all eligible cystic fibrosis patients living in ... The agreement has been reached after
Will now be available on NHS across the UK. Novartis’ Kymriah (tisagenlecleucel) has received routine reimbursement for all eligible UK patients on the NHS, following appraisal from the Scottish Medicines Consortium. . ... treatments. The medicine
More from news
Approximately 5 fully matching, plus 88 partially matching documents found.
December 2018: Scottish Government agrees a deal with Vertex pending submission of Orkambi and Symkevi to Scottish Medicines Consortium (SMC), with interim access possible through the PACS Tier 2 system. ... March 2019: Vertex, NHSE and NICE meet with
Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...